L.-T. Chen

935 total citations
19 papers, 511 citations indexed

About

L.-T. Chen is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L.-T. Chen has authored 19 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L.-T. Chen's work include Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). L.-T. Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Gastric Cancer Management and Outcomes (4 papers). L.-T. Chen collaborates with scholars based in Taiwan, Japan and South Korea. L.-T. Chen's co-authors include Jacqueline Whang‐Peng, Ann‐Lii Cheng, Chao-Jung Tsao, Tsu‐Yi Chao, Pei‐Jer Chen, Wu‐Ching Uen, Hwei‐Fang Tien, Ih‐Jen Su, Chao A. Hsiung and Chih‐Hung Hsu and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

L.-T. Chen

19 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.-T. Chen Taiwan 10 254 238 170 132 115 19 511
Jean‐Baptiste Nousbaum France 13 186 0.7× 188 0.8× 189 1.1× 157 1.2× 130 1.1× 40 545
Shinichi Shibasaki Japan 14 187 0.7× 112 0.5× 178 1.0× 251 1.9× 141 1.2× 37 487
C. Della Corte Italy 11 264 1.0× 205 0.9× 66 0.4× 88 0.7× 48 0.4× 22 433
Claus Kölblinger Austria 8 324 1.3× 142 0.6× 133 0.8× 101 0.8× 59 0.5× 10 466
Kensaku Sanefuji Japan 15 380 1.5× 171 0.7× 147 0.9× 334 2.5× 99 0.9× 29 611
Ryusuke Yamaguchi Japan 4 339 1.3× 161 0.7× 126 0.7× 234 1.8× 127 1.1× 5 504
Juxiang Xiao China 10 163 0.6× 68 0.3× 275 1.6× 107 0.8× 157 1.4× 14 440
France Gay Belgium 10 314 1.2× 186 0.8× 136 0.8× 205 1.6× 142 1.2× 12 552
Hiroaki Nagamatsu Japan 12 388 1.5× 218 0.9× 79 0.5× 126 1.0× 82 0.7× 32 517

Countries citing papers authored by L.-T. Chen

Since Specialization
Citations

This map shows the geographic impact of L.-T. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.-T. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.-T. Chen more than expected).

Fields of papers citing papers by L.-T. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.-T. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.-T. Chen. The network helps show where L.-T. Chen may publish in the future.

Co-authorship network of co-authors of L.-T. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of L.-T. Chen. A scholar is included among the top collaborators of L.-T. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.-T. Chen. L.-T. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chiang, Nai‐Jung, Li-Yuan Bai, Chang‐Fang Chiu, et al.. (2025). A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors. Investigational New Drugs. 43(3). 709–718. 1 indexed citations
2.
3.
Hirano, Hidekazu, Yoichi Naito, Raghav Sundar, et al.. (2024). CHAPTER-GIST-101: A phase I study of pimitespib combined with imatinib in patients with imatinib-refractory gastrointestinal stromal tumor.. Journal of Clinical Oncology. 42(23_suppl). TPS97–TPS97. 1 indexed citations
4.
Yoshino, Takayuki, G. Pentheroudakis, Saori Mishima, et al.. (2020). JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions. Annals of Oncology. 31(7). 861–872. 83 indexed citations
5.
6.
7.
8.
Yoo, Changhoon, Do‐Youn Oh, Hye Jin Choi, et al.. (2018). M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial. Annals of Oncology. 29. viii258–viii259. 15 indexed citations
9.
Satoh, Taroh, L.-T. Chen, Yoon‐Koo Kang, et al.. (2018). A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data. Annals of Oncology. 29. viii206–viii206. 9 indexed citations
10.
Kuo, Sung‐Hsin, Hui‐Jen Tsai, Kun‐Huei Yeh, et al.. (2016). CagA and NFAT co-operatively participate in the lymphomagenesis of gastric MALT lymphoma. Annals of Oncology. 27. vi321–vi321. 1 indexed citations
11.
Chen, L.-T., et al.. (2005). Pulmonary embolism after transcatheter arterial chemoembolization. European Journal of Cancer Care. 14(5). 440–442. 6 indexed citations
12.
Shiah, Her‐Shyong, Ann‐Lii Cheng, Chiun Hsu, et al.. (2005). Phase I–II trial of weekly gemcitabine plus high‐dose 5‐fluorouracil and leucovorin in advanced pancreatic cancer. Journal of Gastroenterology and Hepatology. 21(3). 531–536. 7 indexed citations
13.
Cheng, Ann‐Lii, Chiun Hsu, Yen‐Shen Lu, et al.. (2005). Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48‐h infusion of fluorouracil/leucovorin for advanced pancreatic cancer. Journal of Gastroenterology and Hepatology. 21(5). 874–879. 9 indexed citations
14.
Cheng, Ann‐Lii, Chao A. Hsiung, Ih‐Jen Su, et al.. (2003). Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With Lymphoma. Hepatology. 37(6). 1320–1328. 228 indexed citations
15.
16.
Hsu, Chiun, Chi‐Long Chen, L.-T. Chen, et al.. (2001). Comparison of MALT and non-MALT primary large cell lymphoma of the stomach. Cancer. 91(1). 49–56. 9 indexed citations
17.
18.
Wu, Chew-Wun, et al.. (1998). Percutaneous Transhepatic Duodenal Drainage as an Alternative Approach in Afferent Loop Obstruction with Secondary Obstructive Jaundice in Recurrent Gastric Cancer. CardioVascular and Interventional Radiology. 21(4). 350–353. 21 indexed citations
19.
Chen, L.-T., et al.. (1990). Gastrointestinal Tract Involvement in Hepatocellular Carcinoma: Clinical, Radiological and Endoscopic Studies. Endoscopy. 22(3). 118–123. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Baptiste Nousbaum Breakdown of academic impact, for papers by Shinichi Shibasaki Breakdown of academic impact, for papers by C. Della Corte Breakdown of academic impact, for papers by Claus Kölblinger Breakdown of academic impact, for papers by Kensaku Sanefuji Breakdown of academic impact, for papers by Ryusuke Yamaguchi Breakdown of academic impact, for papers by Juxiang Xiao Breakdown of academic impact, for papers by France Gay Breakdown of academic impact, for papers by Hiroaki Nagamatsu
Rankless by CCL
2026